Long Term Survival in Unresectable Stage IV Esophageal Squamous Cell Carcinoma Treated with Chemoradiation

AUTHORS

Bahar Moeini 1 , Ahmad Ameri 2 , * , Bahram Mofid 2

1 Radiation oncologist, Shahid Beheshti University of Medical Sciences, Andorra

2 Associate professor of radiation oncology, Shahid Beheshti University of Medical Sciences, Iran

How to Cite: Moeini B, Ameri A, Mofid B. Long Term Survival in Unresectable Stage IV Esophageal Squamous Cell Carcinoma Treated with Chemoradiation, Rep Radiother Oncol. 2013 ; 1(1):e2383.

ARTICLE INFORMATION

Reports of Radiotherapy and Oncology: 1 (1); 29-34
Published Online: June 01, 2013
Article Type: Case Report
Received: April 01, 2013
Accepted: May 05, 2013

Crossmark

CHEKING

READ FULL TEXT
Abstract

Background:

Esophageal Squamous Cell Carcinoma is one of the most common GI cancers in Iran. Development of para-aortic lymphadenopathy is classified as stage IV and long term survival is rare. We report a case of esophageal SCC with paraaortic lymphadenopathies, who was treated with systemic and nonsurgical locoregional therapy.

Report of the case:

A 39-year-old female with SCC of the distal esophagus and proximal stomach,  that was unresectable on laparatomy, was referred to our center for palliative treatment. She received six cycles of chemotherapy (Paclitaxel / cisplatin), and then concurrent chemotherapy and radiotherapy to the primary tumor and paraaortic region with a total dose of 5220 centigray (cGy). Six years later, she was still alive without any complaints or disease progression.

Conclusion:

It seems that patients with locally advanced unresectable Esophageal Squamous Cell Carcinoma can be treated radically with systemic and nonsurgical locoregional therapy, to achieve long term survival

Keywords

Esophageal squamous cell carcinoma survival treatment

© 0, Reports of Radiotherapy and Oncology. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.

Fulltext

Full text is available in the PDF.

References

  • 1.

    References are available in the PDF.

  • COMMENTS

    LEAVE A COMMENT HERE: